← 返回

2012 至 2023 年 CAR-T 细胞治疗血液系统恶性肿瘤的文献计量学与知识图谱研究

英文原题:A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.

查看英文原题

A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.

PubMed 2024/07/03(内容时间) Hum Vaccin Immunother Q2 · IF 4.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CAR-T 治疗血液恶性肿瘤近年来受到广泛关注。本研究旨在全面分析2012至2023年该领域的研究现状、发展趋势、热点及新兴主题。研究从Web of Science核心合集获取相关文献,并以文献计量和可视化方法分析3643篇文章,这些论文由72个国家及多家机构合作发表。相关研究逐年增加。分析识别出活跃度最高的国家和机构、引用及发文最多的期刊,以及被引和共被引频次最高的作者,并确定研究热点和六个新兴主题。该研究为希望深入该领域并规划未来方向的研究者提供参考。

展开英文摘要原文

Recently, CAR-T cell therapy in hematological malignancies has received extensive attention. The objective of this study is to gain a comprehensive understanding of the current research status, development trends, research hotspots, and emerging topics pertaining to CAR-T cells in the treatment of hematological malignancies. Articles pertaining to CAR-T cell therapy for hematological malignancies from the years 2012 to 2023 were obtained and assessed from the Web of Science Core Collection (WoSCC).

A bibliometric approach was employed to conduct a scientific, comprehensive, and objective quantitative analysis, as well as a visual analysis, of this particular research domain. A comprehensive analysis was conducted on a corpus of 3643 articles, which were collaboratively authored by 72 countries and various research institutions. CAR-T cell research in treating hematological malignancies shows an increasing trend each year.

Notably, the study identified the countries and institutions displaying the highest level of activity, the journals with the most citations and output, as well as the authors who garnered the highest frequency of citations and co-citations.

Furthermore, the analysis successfully identified the research hotspots and highlighted six emerging topics within this domain.

This study conducted a comprehensive exploration and analysis of the research status, development trends, research hotspots, and emerging topics about CAR-T cells in the treatment of hematological malignancies from 2012 to 2023. The findings of this study will serve as a valuable reference and guide for researchers seeking to delve deeper into this field and determine the future direction of their research.

论文信息

作者
Huang Q、Li H、Zhang Y
单位
Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing, China.China
期刊
Human vaccines & immunotherapeutics2024 Dec 31
原文标识
PubMed 38961667 · DOI 10.1080/21645515.2024.2371664